News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Confluence Announces $4 Million in Series A Financing



9/17/2012 10:00:00 AM

ST. LOUIS--(BUSINESS WIRE)--Confluence Life Sciences, Inc., a biotechnology company focused on the rapid discovery and development of kinase inhibitors to treat cancer and inflammatory disease, today announced a $4 million Series A venture capital financing. Proceeds from the financing will enable Confluence to advance its product candidates and leverage its proprietary technology platform to discover and develop novel therapeutics.

Read at BioSpace.com


comments powered by Disqus
 
 

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES